Phospholipid-polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Molecular Biology

Background:

• Gene silencing with small interfering RNA (siRNA) is a key therapeutic strategy, particularly for cancer.
• Micelle-like nanoparticles (MNPs) were previously developed as gene carriers for plasmid DNA delivery.
• The potential of these MNPs for siRNA delivery required further investigation.

Purpose of the Study:

• To evaluate the efficacy of MNPs as carriers for siRNA delivery.
• To characterize the physicochemical properties of siRNA-loaded MNPs.
• To assess the in vitro performance and safety of MNPs for gene silencing.

Main Methods:

• siRNA was condensed with phospholipid-polyethylenimine (PLPEI) and coated with a PEG/lipid layer to form MNPs.
• Particle size, surface charge, siRNA protection against enzymatic digestion, and cellular uptake were analyzed.
• Gene silencing efficacy was demonstrated using GFP-targeted siRNA in GFP-expressing cells.
• Cytotoxicity was assessed across various cell lines and concentrations.

Main Results:

• MNPs were formed with approximately 200 nm size and neutral surface charge, protecting siRNA from degradation.
• Enhanced cellular uptake of siRNA was observed with MNPs compared to uncoated polyplexes.
• Effective downregulation of GFP gene expression was achieved using GFP-siRNA loaded MNPs.
• MNPs exhibited no significant toxicity across a broad range of concentrations and cell lines.

Conclusions:

• MNPs are effective and safe carriers for siRNA delivery, demonstrating efficient gene silencing.
• The developed MNPs offer a promising platform for siRNA-based therapeutics, especially in oncology.
• Further in vivo studies are warranted to explore the therapeutic potential of MNP-mediated siRNA delivery.